Alembic Pharmaceuticals informs about press release

17 Apr 2025 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Carbamazepine Tablets USP, 200 mg. It enclosed press release of the same.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

776.05 -0.20 (-0.03%)
19-Feb-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.50
Dr. Reddys Lab 1292.70
Cipla 1348.05
Zydus Lifesciences 923.65
Lupin 2233.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×